- Our ambition
- Healthcare ecosystem
- Patient Relationship
- Public and Government Affairs
- Global Code of Conduct
- Expressing concerns
- Preventing corruption
- Relationships with Third Parties
- Personal information and privacy
- Extended Company
You are here
Information notice for CSR
- May 07, 2021 bioMérieux announces the CE marking of the new generation semi-qua...
- April 30, 2021 bioMérieux announces CE-marking of the new MALDI-TOF mass spectrom...
- April 27, 2021 bioMérieux – First-Quarter 2021 Business Review
- April 07, 2021 bioMérieux announces the CE marking of 3 dengue immunoassays on VI...